Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humco is a diversified pharmaceutical company focused on the development, manufacturing, and commercialization of innovative delivery vehicles and over-the-counter (OTC) medicines. Founded in 1872 and headquartered in Texarkana, Texas, the company serves a global customer base of pharmacists, retailers, and institutional care offices. Humco is a leader in the pharmaceutical compounding market, providing proprietary vehicles like SyrSpend SF for oral liquid formulations and various topical bases. In 2018, the company was acquired by Fagron, a global leader in pharmaceutical compounding, to strengthen its presence in the North American market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humco Holding Group.